← Volver atrás
Publicaciones

Oleuropein and its peracetylated derivative negatively regulate osteoclastogenesis by controlling the expression of genes involved in osteoclast differentiation and function

Autores

Angeles Rosillo, Maria , Montserrat-de-la-Paz, Sergio , Abia, Rocio , CASTEJÓN MARTÍNEZ, MARÍA LUISA, Carmen Millan-Linares, Maria , Alarcon-de-la-Lastra, Catalina , Fernandez-Bolanos, Jose G. , Muriana, Francisco J. G.

Publicación externa

No

Medio

Food Funct.

Alcance

Article

Naturaleza

Científica

Cuartil JCR

1

Cuartil SJR

1

Impacto JCR

5.396

Impacto SJR

1.145

Fecha de publicacion

01/05/2020

ISI

000538041500020

Abstract

During chronic inflammation, macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL) have well established effects on gene networks that stimulate osteoclastogenesis, which is the culprit of several bone diseases. In this study, we investigated the anti-osteoclastogenic effects in vitro of oleuropein (OL) and its peracetylated derivative (Per-OL) by exploring the expression level of key hub genes involved in fate decision and lineage commitment, differentiation, and function of human blood monocyte-derived osteoclasts. Monocytes were purified from peripheral blood mononuclear cells of healthy individuals using commercial antibodies coated with magnetic beads and treated with M-CSF/RANKL in the presence or absence of OL or Per-OL (25 and 50 mu M) for 6 days. We demonstrated that OL and especially Per-OL impair transcriptional gene circuits able to support osteoclastogenesis from human blood monocytes. Our results indicate that OL and notably Per-OL are promising candidates to control osteoclastogenesis.

Miembros de la Universidad Loyola